Patient Cohorts in the Trial
| Cohort | Patient no. | CC49 fusion protein (mg/m2) | Interval 1 (h) | sCA (mg/m2) | Interval 2 (h) | 111In/90Y-DOTA-biotin |
|---|---|---|---|---|---|---|
| 1 | 1–3 | 160 | 72 | 45 | 24 | 111In-DOTA-biotin, 1.3 mg/m2 |
| 2 | 4–6 | 160 | 48 | 45 | 24 | 111In- and 90Y-DOTA-biotin, 1.3 mg/m2 |
| 3 | 7–9 | 160 | 48 | 45 | 24 | 111In- and 90Y-DOTA-biotin, 0.65 mg/m2 |